Industry Background:
The abdominal aortic stent graft is a system or device that consists of permanent implantable flexible fabric like polyester supported by the metal framework with a thin tube used to place the stent-graft which is also called a catheter. It is used for providing support and repairs a weakened and bulging section of the artery or aorta below the renal arteries. As the abdominal aortic aneurysm disease is rising with the growing aged population the demand for abdominal aortic stent graft market is expected to grow in the forecasted year. However, the adverse effect and infection associated with stent-graft might hamper the growth of the market. The stent-graft infection has been reported at 0.3–3.6% of EVAR-treated patients and the mortality rate of stent-graft infection is high and ranges from 25% to 50%.This growth is primarily driven by Rising Abdominal Aortic Aneurysm Disease
.
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Forecast Period | 2023-2028 |
Volume Unit | K Units |
Value Unit | USD (Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
The Health Care Equipment sector in the
region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Medtronic plc (Ireland), Cook Medical Incorporated (United States), W. L. Gore & Associates, Inc. (United States), Endologix, Inc. (United States), MicroPort Scientific Corporation (China), Terumo Corporation (Japan), LeMaitre Vascular, Inc. (United States), Bentley Innomed GmbH (Germany) and Cardinal Health (Switzerland), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
In June 2023, NAMSA, a prominent global Contract Research Organization (CRO) specializing in MedTech, and Terumo Aortic, a company known for its development of medical devices focused on the aorta, officially joined forces. They have established a strategic outsourcing partnership with the aim of accelerating and bringing to market Terumo Aortic's groundbreaking products for aortic disease.The market for abdominal aortic stent grafts is highly competitive, with several key players vying for market share. These companies strive to develop and offer innovative and technologically advanced solutions for the treatment of abdominal aortic aneurysms. They focus on improving the efficacy, safety, and durability of their stent grafts while addressing the specific needs of patients and healthcare professionals. The competitive landscape is characterized by ongoing research and development efforts, strategic partnerships, and mergers and acquisitions to strengthen product portfolios and expand market reach. Companies in this space continually invest in clinical studies and trials to demonstrate the effectiveness and long-term outcomes of their stent grafts. Ultimately, the competitive landscape is driven by the goal of providing high-quality and cost-effective solutions to patients in need of abdominal aortic aneurysm treatment.
Regulatory Insights:
"In the United States, there is currently only one fenestrated graft Food and Drug Administration-approved for commercial use, the Cook Zenith Fenestrated AAA Endovascular Graft (Cook Medical, Bloomington, IN). This device is indicated for juxtarenal AAA and incorporates up to 3 visceral vessels. The device is custom made for a patient’s anatomy and requires 6 weeks for manufacturing and delivery. It is, therefore, not an option for patients needing urgent or emergent repair. The use of this device for elective juxtarenal AAA repair is associated with high technical success, low-perioperative morbidity and mortality, and excellent long-term target vessel patency. However, a substantial portion of patients with complex AAA does not meet the anatomic criteria of this device and no commercially available endovascular treatment option is available."
Influencing Trend:
The Emergence of EVAS Procedure Due to Less Risk Involved and Technological Advancement Device
Market Growth Drivers:
Rising Abdominal Aortic Aneurysm Disease and Growing Geriatric Population Across the World
Challenges:
Complexities Involved with Stent Graft
Restraints:
Infections and Side Effects Associated with Stent Graft and Stringent Regulatory Guidelines Abdominal Aortic Stent Graft
Opportunities:
Awareness About the Abdominal Aortic Aneurysm Disease and Investment in Research and Development Activities
AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.
Data Sources of Abdominal Aortic Stent Graft Market Study
Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Abdominal Aortic Stent Graft Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.
The primary interviews and data collected as per the below protocols: By Designation: C-Level, D-Level, Others
By Company Type: Tier 1, Tier 2, Tier 3
Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Abdominal Aortic Stent Graft players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.
Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
Against this Challenging Backdrop, Abdominal Aortic Stent Graft Study Sheds Light on
The Abdominal Aortic Stent Graft Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Abdominal Aortic Stent Graft industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
Where Abdominal Aortic Stent Graft industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.